ÂÜÀòÂÒÂ×

Rene Hubert currently serves as the Director of Expression & Cell Engineering at Amgen since October 2017, following a role as Principal Scientist in Biologics Optimization at the same company. Prior experience includes serving as Senior Principal Scientist at Astellas Pharma US from February 2012 to September 2017, Alliance Manager Consultant at Xencor for a brief period in 2011-2012, and Bioinformatics Consultant at Acorda Therapeutics, Inc. from May 2010 to February 2012. Earlier positions include Lead Scientist at Xencor from 2001 to 2007 and Research Scientist at Agensys, Inc. from 1997 to 2001. Rene Hubert's educational background includes a Post Doctoral Fellowship in Genome Sciences/Genomics from Cedars-Sinai Medical Center, a PhD in Molecular Biology from the University of Southern California, and a Bachelor of Science in Biology and Chemistry from the University of Waterloo.